A U.S. congressional oversight committee has opened an investigation into the Drug Enforcement Administration (DEA), the federal agency responsible for combating drug trafficking within the United States. Lawmakers say they want to understand how such large quantities of fentanyl — a synthetic opioid many times more potent than morphine — have managed to slip past enforcement efforts and reach communities across the country.
Fentanyl has become the leading driver of overdose deaths in the U.S. in recent years, fueling what public health officials call an ongoing opioid crisis. Much of the drug is believed to originate from precursor chemicals produced overseas, often trafficked through Mexico before crossing into the United States.
The committee’s inquiry centers on whether the DEA has failed to adequately intercept shipments or coordinate effectively with other agencies, allowing what lawmakers describe as an “astonishing” volume of the drug to circulate domestically. The investigation is expected to examine internal agency practices, interagency cooperation, and whether current strategies are keeping pace with the scale of the crisis.
For American readers, it’s worth noting that congressional oversight committees have the power to summon officials, request internal documents, and hold public hearings — tools that could shed new light on gaps in U.S. drug enforcement policy.
To read the full report and follow further developments, check out the original article from La Jornada.
Image: CBP Photography.